FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

Abbott recently reported year over year sales of $10.6bn in its third quarter of 2024 ... UK facility and create up to 400 ...

The company says around six million people across 60 countries now use its Freestyle Libre glucose monitors which avoid the ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million.

Do you struggle to fall asleep at night, or regularly wake up feeling tired? If so, you might find answers by learning about ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

You might want to solve today's puzzle before reading further! Carpe Diem (Freestyle) Constructor: Dena R. Witkes Editor: Amanda RafkinStart the day smarter. Get all the news ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...